0.9383119524695255		SimpleArgument(Massachusetts,List([78, 91)))	Relation(sells,List([92, 97)))	SimpleArgument(genomic analysis diagnostics for circulating cancers,List([98, 150)))	Foundation Medicine, Inc. is a public American company based in Cambridge, Massachusetts which develops, manufactures and sells genomic analysis diagnostics for solid and circulating cancers.
0.9383119524695255		SimpleArgument(Massachusetts,List([78, 91)))	Relation(sells,List([92, 97)))	SimpleArgument(genomic analysis diagnostics for solid cancers,List([98, 144)))	Foundation Medicine, Inc. is a public American company based in Cambridge, Massachusetts which develops, manufactures and sells genomic analysis diagnostics for solid and circulating cancers.
0.9445721975409912		SimpleArgument(Foundation Medicine,List([0, 19)))	Relation(is,List([28, 30)))	SimpleArgument(a public American company based in Cambridge ,,List([31, 77)))	Foundation Medicine, Inc. is a public American company based in Cambridge, Massachusetts which develops, manufactures and sells genomic analysis diagnostics for solid and circulating cancers.
0.9317179137747896	Context(Foundation Medicine , Inc . is a public American company manufactures,List([0, 104)))	SimpleArgument(Foundation Medicine,List([0, 19)))	Relation(is,List([28, 30)))	SimpleArgument(a public American company based in Cambridge,List([31, 75)))	Foundation Medicine, Inc. is a public American company based in Cambridge, Massachusetts which develops, manufactures and sells genomic analysis diagnostics for solid and circulating cancers.
0.9754904542587453		SimpleArgument(Foundation Medicine , Inc . is a public American company,List([0, 56)))	Relation(manufactures,List([92, 104)))	SimpleArgument(Massachusetts,List([78, 91)))	Foundation Medicine, Inc. is a public American company based in Cambridge, Massachusetts which develops, manufactures and sells genomic analysis diagnostics for solid and circulating cancers.
0.9314904193639496		SimpleArgument(a public American company,List([31, 56)))	Relation(based in,List([57, 62), [63, 65)))	SpatialArgument(Cambridge,List([66, 75)))	Foundation Medicine, Inc. is a public American company based in Cambridge, Massachusetts which develops, manufactures and sells genomic analysis diagnostics for solid and circulating cancers.
0.9445721975409912		SimpleArgument(Foundation Medicine,List([0, 19)))	Relation(is,List([28, 30)))	SimpleArgument(a public American company based in Cambridge , Massachusetts,List([31, 91)))	Foundation Medicine, Inc. is a public American company based in Cambridge, Massachusetts which develops, manufactures and sells genomic analysis diagnostics for solid and circulating cancers.
0.9186941924198344		SimpleArgument(The company's tests,List([0, 19)))	Relation(are based on,List([20, 29), [30, 32)))	SimpleArgument(next-generation sequencing technology,List([33, 70)))	The company's tests are based on next-generation sequencing technology.
0.9212499880074402	Context(its stock is traded,List([48, 67)))	SimpleArgument(Foundation Medicine Foundation Medicine, Inc.,List([0, 19)))	Relation(went public in,List([20, 24), [25, 31), [32, 34)))	TemporalArgument(August 2013,List([35, 46)))	Foundation Medicine went public in August 2013; its stock is traded on the New York Stock Exchange under the symbol FMI.
0.8197182361011437	Context(its stock is traded,List([48, 67)))	SimpleArgument(Foundation Medicine Foundation Medicine, Inc.,List([0, 19)))	Relation(went,List([20, 24)))	SimpleArgument(public,List([25, 31)))	Foundation Medicine went public in August 2013; its stock is traded on the New York Stock Exchange under the symbol FMI.
0.5160713768404979		SimpleArgument(its stock,List([48, 57)))	Relation(is traded under,List([58, 67), [99, 104)))	SpatialArgument(the symbol FMI,List([105, 119)))	Foundation Medicine went public in August 2013; its stock is traded on the New York Stock Exchange under the symbol FMI.
0.620258514064451		SimpleArgument(its stock,List([48, 57)))	Relation(is traded on,List([58, 67), [68, 70)))	SpatialArgument(the New York Stock Exchange,List([71, 98)))	Foundation Medicine went public in August 2013; its stock is traded on the New York Stock Exchange under the symbol FMI.
0.515999972820282		SimpleArgument(Foundation Medicine Foundation Medicine, Inc.,List([0, 0)))	Relation(had [number of] employees,List([0, 0)))	SimpleArgument(275,List(null))	As of December 2014, the company had 275 employees.
0.9426897092628826		SimpleArgument(Foundation Medicine Foundation Medicine, Inc.,List([21, 32)))	Relation(had 275 employees As,List([0, 2), [33, 40), [41, 50)))	TemporalArgument(of December 2014,List([3, 19)))	As of December 2014, the company had 275 employees.
0.9251282565798027		SimpleArgument(Foundation Medicine Foundation Medicine, Inc.,List([21, 32)))	Relation(had,List([33, 36)))	SimpleArgument(275 employees,List([37, 50)))	As of December 2014, the company had 275 employees.
0.944056173886228		SimpleArgument(the FoundationOne Heme diagnostic test,List([50, 88)))	Relation(being for,List([89, 94), [95, 98)))	SimpleArgument(blood cancers,List([99, 112)))	The company's flagship product was FoundationOne, the FoundationOne Heme diagnostic test being for blood cancers.
0.9520806423106366		SimpleArgument(The company's flagship product,List([0, 30)))	Relation(was,List([31, 34)))	SimpleArgument(FoundationOne,List([35, 48)))	The company's flagship product was FoundationOne, the FoundationOne Heme diagnostic test being for blood cancers.
0.9426897092628826		SimpleArgument(Foundation Medicine Foundation Medicine, Inc.,List([19, 30)))	Relation(established respectively In,List([0, 2), [31, 42), [115, 127)))	TemporalArgument(December 2014,List([3, 16)))	In November and December 2014, the company established agreements with COTA (Cancer Outcomes Tracking and Analysis) and Flatiron Health, respectively, aimed at increasing the volume of genomic and clinical patient data available to it.
0.8726638078217275		SimpleArgument(Foundation Medicine Foundation Medicine, Inc.,List([14, 25)))	Relation(aimed at,List([125, 130), [131, 133)))	SimpleArgument(increasing the volume of clinical patient data available to it,List([134, 196)))	In November and December 2014, the company established agreements with COTA (Cancer Outcomes Tracking and Analysis) and Flatiron Health, respectively, aimed at increasing the volume of genomic and clinical patient data available to it.
0.8726638078217275		SimpleArgument(Foundation Medicine Foundation Medicine, Inc.,List([14, 25)))	Relation(aimed at,List([125, 130), [131, 133)))	SimpleArgument(increasing the volume of genomic patient data available to it,List([134, 195)))	In November and December 2014, the company established agreements with COTA (Cancer Outcomes Tracking and Analysis) and Flatiron Health, respectively, aimed at increasing the volume of genomic and clinical patient data available to it.
0.9426897092628826		SimpleArgument(Foundation Medicine Foundation Medicine, Inc.,List([14, 25)))	Relation(established respectively In,List([0, 2), [26, 37), [110, 122)))	TemporalArgument(November,List([3, 11)))	In November and December 2014, the company established agreements with COTA (Cancer Outcomes Tracking and Analysis) and Flatiron Health, respectively, aimed at increasing the volume of genomic and clinical patient data available to it.
0.8557456177405949		SimpleArgument(Roche,List([9, 14)))	Relation(announced a plan to purchase a 56.3 % stake in the company through a US$ 780 million purchase of newly issued shares In,List([0, 2), [15, 122), [123, 129)))	TemporalArgument(2015,List([3, 7)))	In 2015, Roche announced a plan to purchase a 56.3% stake in the company through a US$780 million purchase of newly issued shares.
0.9484177987969541		SimpleArgument(Roche,List([9, 14)))	Relation(announced,List([15, 24)))	SimpleArgument(a plan to purchase a 56.3% stake in the company through a US$780 million purchase of newly issued shares,List([25, 129)))	In 2015, Roche announced a plan to purchase a 56.3% stake in the company through a US$780 million purchase of newly issued shares.
0.9492443998687922		SimpleArgument(Roche,List([0, 5)))	Relation(announced,List([11, 20)))	SimpleArgument(an intention to invest US$ 400 million toward Foundation Medicine 's operations , R&D activities,List([21, 117)))	Roche also announced an intention to invest US$400 million toward Foundation Medicine's operations, development and R&D activities.
0.9492443998687922		SimpleArgument(Roche,List([0, 5)))	Relation(announced,List([11, 20)))	SimpleArgument(an intention to invest US$ 400 million toward Foundation Medicine 's operations , development activities,List([21, 125)))	Roche also announced an intention to invest US$400 million toward Foundation Medicine's operations, development and R&D activities.
0.9445721975409912		SimpleArgument(Foundation Medicine Foundation Medicine, Inc.,List([0, 19)))	Relation(has,List([25, 28)))	SimpleArgument(business agreements with Novartis,List([29, 62)))	Foundation Medicine also has business agreements with Johnson & Johnson and Novartis.
0.9445721975409912		SimpleArgument(Foundation Medicine Foundation Medicine, Inc.,List([0, 19)))	Relation(has,List([25, 28)))	SimpleArgument(business agreements with Johnson,List([29, 61)))	Foundation Medicine also has business agreements with Johnson & Johnson and Novartis.
0.9487151045975787		SimpleArgument(The company's chief executive officer,List([0, 37)))	Relation(is,List([44, 46)))	SimpleArgument(Michael J. Pellini,List([47, 65)))	The company's chief executive officer (CEO) is Michael J. Pellini.
0.9487151045975787		SimpleArgument(The company's chief operating officer,List([0, 37)))	Relation(is,List([44, 46)))	SimpleArgument(Steve Kafka,List([47, 58)))	The company's chief operating officer (COO) is Steve Kafka.
0.9487151045975787		SimpleArgument(The company's chief commercial officer,List([0, 38)))	Relation(is,List([45, 47)))	SimpleArgument(David Daly,List([48, 58)))	The company's chief commercial officer (CCO) is David Daly.
